Enanta Pharmaceuticals, Inc. To Present At The JMP Securities Life Sciences Conference
WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc., (NASDAQ:ENTA) a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today announced that Jay R. Luly, Ph.D., President and Chief Executive Officer, will present a corporate overview followed by a question and answer session with investors on June 23, 2015 at 10:30 a.m. ET during the JMP Securities Life Sciences Conference.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.